Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
GTCFX-PR 5-GTCPrime Signs Off From iFX Expo Hong Kong 2026 After Two Days of Insight and Connection
-
TomTom and DeepRoute.ai partner to advance AI-based automated driving
-
Aalberts reports the completion of its share buyback 2026 programme
-
Telia Lietuva restructures operations and plans up to 85 redundancies
-
Start of Day Message
-
Damian Thompson to become Chief Executive Officer of LHV Bank Limited
-
VALLOUREC AWARDED MAJOR CONTRACT BY TOTALENERGIES FOR THE ABSHERON GAS FIELD IN AZERBAIJAN
-
Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity
-
Aktsiaselts Infortar own share acquisition transactions
-
Technip Energies awarded large EPC contract by HPCL for Mumbai refinery modernization project in India
-
EfTEN Real Estate Fund AS NAV per share increased by 0.9% in September to €20.41
-
Sysco Urges Teamsters Locals 630 and 848 to End Strike as Parties Agree Economic Terms
-
From Rigorous Long-Distance Testing to Music on the Move: OMODA & JAECOO’s Super Hybrid Marathon Reimagines the Road Trip
-
From Rigorous Long-Distance Testing to Music on the Move: OMODA & JAECOO’s Super Hybrid Marathon Reimagines the Road Trip
-
Two Model Premieres, Two Distinct Vibes: OMODA & JAECOO Tease More Surprises for the 2026 Paris Motor Show
-
Two Model Premieres, Two Distinct Vibes: OMODA & JAECOO Tease More Surprises for the 2026 Paris Motor Show
-
SkyAI Announces Intention to Commence Cash Tender Offer to Purchase Common Stock and Pre-funded Warrants at $3.00 Per Share/Pre-funded Warrant
-
ATK Phantom Highlights the Evolution of High-Performance Gaming Mice
-
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Granted FDA Fast Track Designation for First-Line Advanced or Metastatic Biliary Tract Cancer
-
September 2026 Quarterly Results Conference Call
-
InnoCare Announces Approval of Clinical Trial of Bispecific Antibody ICP-B161 Targeting TL1A and IL-23p19 in China
-
New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives the $1 ADA Dream
-
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
-
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
-
Stellantis Unveils Six Concept Cars “The Night Before” the Paris Motor Show
-
Crypto News: Remittix Opens PayFi to 1,000 Holders as Bitcoin Price Prediction Explodes to $200,000 and Solana’s 200ms Upgrade Fuels a $300 SOL Target
-
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
-
Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting
-
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
-
Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure
-
Jindong, Zhejiang: Building on the Yangtze River Delta Sci-Tech Innovation Corridor, Seizing the AI Wave to Forge New Industrial Strengths
-
‘Moms Offering More’ Launches Limited Crewneck Collaboration With Archewell Philanthropies in Support of Alliance for Moms
-
Crypto News: Remittix Sets $0.46 Final Presale Price as XRP Price Prediction Targets $20 and Zcash’s Quantum-Ready Roadmap Sparks a $3,000 ZEC Forecast
-
Geely Auto Group Launches Its First Electrified Off-Road Flagship SUV
-
FREELANDER Outlines Global Validation Programme for FREELANDER 8 Ahead of First International Test Drive
-
The Cybersecurity Talent Gap Is an Economic Problem. Tolulope Michael Is Betting Non-Technical Workers Are the Answer
-
Mediacom Mobilizes Recovery Efforts Following Hurricane Isaias
-
Pomona College launches $530M campaign to expand access; breaks ground on Center for Global Engagement
-
Climate Solutions Company Treasure Carbon Brings Climate Finance to Nepal for Long-Term Climate Action
-
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
-
41caijing to Bring Local Team to EICMA 2026, Providing PR Support for Chinese Two-Wheel Brands
-
Winseed Successfully Concludes Its Participation at IAA TRANSPORTATION 2026, Showcasing New Insights into Automotive AI and Global Brand Visibility
-
Evolving Luxury and Intelligence: LUXEED Set to Launch Global Media Drive
-
The Pulse Lives on with 550,000 Users: Countdown to the 2026 EXEED International User Summit
-
High Impact Awards Announces 2026 Winners in Four Categories in Partnership With USA TODAY
-
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Ensign Group, Inc. (NASDAQ: ENSG): Graba
-
When a Hybrid Marathon Meets Live Music: OMODA & JAECOO Sets the Stage for a New Vibe in Mobility
-
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
-
Corza Medical Launches Expanded Blink Single-Use Custom Packs and First-of-Its-Kind Microsurgical Knife Manufacturing Process
-
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
